Parkinson Society Canada

Parkinson Society Canada

November 15, 2010 12:52 ET

Media Advisory: Ottawa Scientists Zero in on Causes and Treatment of Parkinson's Through Study of Proteins, Gene Mutations and Potential Drug Treatments

OTTAWA, ONTARIO--(Marketwire - Nov. 15, 2010) -

WHO: Parkinson Society Ottawa and Parkinson Society Canada
WHAT: University of Ottawa scientists Dr. Juliana Tomlinson, Dr. Michael Schlossmacher, Dr. David Park, and Dr. Mohammad Parsanejed, share $120,000 in research grants from Parkinson Society Canada to help to identify the causes of Parkinson's and how to improve the quality of life for Canadian's living with the disease. While the quest for a cure continues, earlier diagnosis and identifying new therapies that will halt or slow the progression of Parkinson's are two key priorities for Canada's Parkinson's research community.
  Parkinson SuperWalk participants celebrate success and meet the researchers their fundraising efforts support. Grant recipients shed light on their work and hope for the future.
  Photo and interview opportunities with people with Parkinson's and research scientists.
WHERE: Civic Campus (Ottawa Hospital)
  1053 Carling Avenue
  Amphitheatre – 1st floor; (Main entrance of hospital)
  Ottawa, ON K1Y 4E9
WHEN: Tuesday, November 16, 2010
  4:00 p.m – 5:30 p.m.
WHY: Over 100,000 Canadians hold hope that new research will uncover the cause and find a cure For Parkinson's disease. Canada, and Ottawa in particular, is home to some of the world's most renowned Parkinson's researchers.
MORE: For more information about research and research grants, visit (Research & Clinical Programs)

Contact Information